Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine

NCT01407497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: DNA HIVIS and MVA-CMDR
BIOLOGICAL: DNA HIVIS and MVA-CMDR
BIOLOGICAL: Saline solution
BIOLOGICAL: Saline solution

Sponsor

Instituto Nacional de Saúde, Mozambique

Collaborators

[object Object]
[object Object]